CRTX vs. TGR, PXC, CLA, VAST, SML, FRG, BMN, PYX, GROC, and CTL
Should you be buying CRISM Therapeutics stock or one of its competitors? The main competitors of CRISM Therapeutics include Tirupati Graphite (TGR), Phoenix Copper (PXC), Celsius Resources (CLA), Vast Resources (VAST), Strategic Minerals (SML), Firering Strategic Minerals (FRG), Bushveld Minerals (BMN), PYX Resources (PYX), GreenRoc Mining (GROC), and CleanTech Lithium (CTL). These companies are all part of the "other industrial metals & mining" industry.
CRISM Therapeutics vs.
Tirupati Graphite (LON:TGR) and CRISM Therapeutics (LON:CRTX) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their risk, community ranking, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.
Tirupati Graphite has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, CRISM Therapeutics has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500.
CRISM Therapeutics has a net margin of 0.00% compared to Tirupati Graphite's net margin of -81.93%. CRISM Therapeutics' return on equity of -13.12% beat Tirupati Graphite's return on equity.
3.4% of Tirupati Graphite shares are held by institutional investors. 35.9% of Tirupati Graphite shares are held by company insiders. Comparatively, 68.8% of CRISM Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Tirupati Graphite and CRISM Therapeutics both received 0 outperform votes by MarketBeat users.
CRISM Therapeutics has lower revenue, but higher earnings than Tirupati Graphite. CRISM Therapeutics is trading at a lower price-to-earnings ratio than Tirupati Graphite, indicating that it is currently the more affordable of the two stocks.
In the previous week, Tirupati Graphite had 1 more articles in the media than CRISM Therapeutics. MarketBeat recorded 1 mentions for Tirupati Graphite and 0 mentions for CRISM Therapeutics. Tirupati Graphite's average media sentiment score of 0.00 equaled CRISM Therapeutics'average media sentiment score.
Summary
Tirupati Graphite beats CRISM Therapeutics on 7 of the 11 factors compared between the two stocks.
Get CRISM Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CRISM Therapeutics Competitors List
Related Companies and Tools
This page (LON:CRTX) was last updated on 5/25/2025 by MarketBeat.com Staff
Buy CRTX Stock Free CRTX Stock Alerts